Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity

Influx of Ca2+ ions through α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors contributes to neuronal damage in stroke, epilepsy, and neurodegenerative disorders such as ALS. The Ca2+ permeability of AMPA receptors is largely determined by the glutamate receptor 2 (GluR2) subunit, receptors lacking GluR2 being permeable to Ca2+ ions. We identified a difference in GluR2 expression in motor neurons from two rat strains, resulting in a difference in vulnerability to AMPA receptor-mediated excitotoxicity both in vitro and in vivo. Astrocytes from the ventral spinal cord were found to mediate this difference in GluR2 expression in motor neurons. The presence of ALS-causing mutant superoxide dismutase 1 in astrocytes abolished their GluR2-regulating capacity and thus affected motor neuron vulnerability to AMPA receptor-mediated excitotoxicity. These results reveal a mechanism through which astrocytes influence neuronal functioning in health and disease.

[1]  B. Seilheimer,et al.  Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis‐like disease , 2006, Journal of neuroscience research.

[2]  A. Levey,et al.  Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis , 1995, Annals of neurology.

[3]  M. Hediger,et al.  Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate , 1996, Neuron.

[4]  S. Heinemann,et al.  Ca2+ permeability of KA-AMPA--gated glutamate receptor channels depends on subunit composition , 1991, Science.

[5]  W. Robberecht,et al.  Ca2+-permeable AMPA receptors and selective vulnerability of motor neurons , 2000, Journal of the Neurological Sciences.

[6]  J. Rothstein,et al.  Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS) , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  W. Robberecht,et al.  Protective Effect of Parvalbumin on Excitotoxic Motor Neuron Death , 2002, Experimental Neurology.

[8]  M. Bennett,et al.  Knockdown of AMPA Receptor GluR2 Expression Causes Delayed Neurodegeneration and Increases Damage by Sublethal Ischemia in Hippocampal CA1 and CA3 Neurons , 1999, The Journal of Neuroscience.

[9]  A. Prochiantz,et al.  MAP2 expression and neuritic outgrowth and branching are coregulated through region-specific neuro-astroglial interactions , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[10]  P. Ince,et al.  Quantitative assessment of AMPA receptor mRNA in human spinal motor neurons isolated by laser capture microdissection , 2002, Neuroreport.

[11]  Kevin Eggan,et al.  Non–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS model , 2007, Nature Neuroscience.

[12]  Global Ischemia Induces Downregulation of Glur2 mRNA and Increases AMPA Receptor-Mediated Ca2+ Influx in Hippocampal CA1 Neurons of Gerbil , 1997 .

[13]  I. Kanazawa,et al.  Human spinal motoneurons express low relative abundance of GluR2 mRNA: an implication for excitotoxicity in ALS , 2003, Journal of neurochemistry.

[14]  W. Robberecht,et al.  GluR2-dependent properties of AMPA receptors determine the selective vulnerability of motor neurons to excitotoxicity. , 2002, Journal of neurophysiology.

[15]  T. Parks,et al.  Characterization of the AMPA‐Activated Receptors Present on Motoneurons , 2000, Journal of neurochemistry.

[16]  W. Robberecht,et al.  The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis , 2003, Neuroscience Letters.

[17]  W. Faigle,et al.  Cells release prions in association with exosomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  W. Robberecht,et al.  Upregulation of HSP27 in a Transgenic Model of ALS , 2002, Journal of neuropathology and experimental neurology.

[19]  W. Wong,et al.  Molecular diversity of astrocytes with implications for neurological disorders. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Calcium handling proteins in isolated spinal motoneurons. , 1999, Life sciences.

[21]  Hynek Wichterle,et al.  Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons , 2007, Nature Neuroscience.

[22]  P. Seeburg,et al.  Late-onset motoneuron disease caused by a functionally modified AMPA receptor subunit. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[23]  W. Robberecht,et al.  AMPA Receptor Calcium Permeability, GluR2 Expression, and Selective Motoneuron Vulnerability , 2000, The Journal of Neuroscience.

[24]  S. Itohara,et al.  Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model. , 2004, Human molecular genetics.

[25]  Jeffrey D. Rothstein,et al.  From charcot to lou gehrig: deciphering selective motor neuron death in als , 2001, Nature Reviews Neuroscience.

[26]  S. Mignani,et al.  RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis. , 2001, The Journal of pharmacology and experimental therapeutics.

[27]  M. Bennett,et al.  Ischemic preconditioning acts upstream of GluR2 down-regulation to afford neuroprotection in the hippocampal CA1 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  E. Aronica,et al.  Aurintricarboxylic acid prevents GLUR2 mRNA down-regulation and delayed neurodegeneration in hippocampal CA1 neurons of gerbil after global ischemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  P. Seeburg,et al.  RNA editing in brain controls a determinant of ion flow in glutamate-gated channels , 1991, Cell.

[30]  W. Robberecht,et al.  GluR2 Deficiency Accelerates Motor Neuron Degeneration in a Mouse Model of Amyotrophic Lateral Sclerosis , 2005, Journal of neuropathology and experimental neurology.

[31]  W. Robberecht,et al.  Glial cells potentiate kainate-induced neuronal death in a motoneuron-enriched spinal coculture system , 1998, Brain Research.

[32]  Minh N. H. Nguyen,et al.  Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice , 2003, Science.

[33]  G. Ming,et al.  Correction of humoral derangements from mutant superoxide dismutase 1 spinal cord , 2006, Annals of neurology.

[34]  S. Lipton,et al.  Excitatory amino acids as a final common pathway for neurologic disorders. , 1994, The New England journal of medicine.

[35]  A novel splice mutation of HERG in a Chinese family with long QT syndrome , 2005 .

[36]  W. Robberecht,et al.  The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. , 2006, Biochimica et biophysica acta.

[37]  M. Lazdunski,et al.  Linolenic acid prevents neuronal cell death and paraplegia after transient spinal cord ischemia in rats. , 2003, Journal of vascular surgery.

[38]  W. Robberecht,et al.  Chloride Influx Aggravates Ca2+-Dependent AMPA Receptor-Mediated Motoneuron Death , 2003, The Journal of Neuroscience.